The Centers for Disease Control and Prevention (CDC) recommends pre-exposure prophylaxis (PrEP) as an HIV prevention strategy. Taking PrEP medication as prescribed reduces the risk of getting HIV via sexual contact by about 99% and reduces the risk of getting HIV by at least 74% among persons who inject drugs (PWID). Two medications, Truvada® (emtricitabine and tenofovir disoproxil fumarate) and Descovy® (emtricitabine and tenofovir alafenamide) are approved for daily use as HIV PrEP.

Campus Center Clinic
IUPUI Campus Center, CE 213
420 University Blvd

Coleman Hall Clinic
Coleman Hall, CF 100
1140 W. Michigan Street
317-278-6929 fax